148 related articles for article (PubMed ID: 2199477)
1. Genetic abnormalities in sporadic parathyroid adenomas.
Friedman E; Bale AE; Marx SJ; Norton JA; Arnold A; Tu T; Aurbach GD; Spiegel AM
J Clin Endocrinol Metab; 1990 Aug; 71(2):293-7. PubMed ID: 2199477
[TBL] [Abstract][Full Text] [Related]
2. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors.
Rosenberg CL; Kim HG; Shows TB; Kronenberg HM; Arnold A
Oncogene; 1991 Mar; 6(3):449-53. PubMed ID: 2011400
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma.
Arnold A; Kim HG; Gaz RD; Eddy RL; Fukushima Y; Byers MG; Shows TB; Kronenberg HM
J Clin Invest; 1989 Jun; 83(6):2034-40. PubMed ID: 2723071
[TBL] [Abstract][Full Text] [Related]
4. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
[TBL] [Abstract][Full Text] [Related]
6. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.
Gicquel C; Bertagna X; Schneid H; Francillard-Leblond M; Luton JP; Girard F; Le Bouc Y
J Clin Endocrinol Metab; 1994 Jun; 78(6):1444-53. PubMed ID: 7911125
[TBL] [Abstract][Full Text] [Related]
7. Clonal loss of one chromosome 11 in a parathyroid adenoma.
Arnold A; Kim HG
J Clin Endocrinol Metab; 1989 Sep; 69(3):496-9. PubMed ID: 2569472
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific regulatory regions of the PTH gene localized by novel chromosome 11 rearrangement breakpoints in a parathyroid adenoma.
Mallya SM; Wu HI; Saria EA; Corrado KR; Arnold A
J Bone Miner Res; 2010 Dec; 25(12):2606-12. PubMed ID: 20641034
[TBL] [Abstract][Full Text] [Related]
9. A possible tumor suppressor gene for parathyroid adenomas.
Iwasaki H
Int Surg; 1996; 81(1):71-6. PubMed ID: 8803711
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability in sporadic parathyroid adenoma.
Sarquis M; Friedman E; Boson WL; Gomez RS; Dias AF; De Marco L
J Clin Endocrinol Metab; 2000 Jan; 85(1):250-2. PubMed ID: 10634395
[TBL] [Abstract][Full Text] [Related]
11. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
[TBL] [Abstract][Full Text] [Related]
12. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas.
Palanisamy N; Imanishi Y; Rao PH; Tahara H; Chaganti RS; Arnold A
J Clin Endocrinol Metab; 1998 May; 83(5):1766-70. PubMed ID: 9589690
[TBL] [Abstract][Full Text] [Related]
13. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
Tahara H; Smith AP; Gaz RD; Arnold A
J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
[TBL] [Abstract][Full Text] [Related]
14. Studies in a kindred with parathyroid carcinoma.
Streeten EA; Weinstein LS; Norton JA; Mulvihill JJ; White BJ; Friedman E; Jaffe G; Brandi ML; Stewart K; Zimering MB
J Clin Endocrinol Metab; 1992 Aug; 75(2):362-6. PubMed ID: 1639936
[TBL] [Abstract][Full Text] [Related]
15. The molecular biology of parathyroid disease.
Backdahl M; Howe JR; Lairmore TC; Wells SA
World J Surg; 1991; 15(6):756-62. PubMed ID: 1685045
[TBL] [Abstract][Full Text] [Related]
16. Etiologies of parathyroid gland dysfunction in primary hyperparathyroidism.
Marx SJ
J Bone Miner Res; 1991 Oct; 6 Suppl 2():S19-24; discussion S31-2. PubMed ID: 1684885
[TBL] [Abstract][Full Text] [Related]
17. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
Välimäki S; Forsberg L; Farnebo LO; Larsson C
Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid tumor suppressor on 1p: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate.
Tahara H; Smith AP; Gaz RD; Zariwala M; Xiong Y; Arnold A
J Bone Miner Res; 1997 Sep; 12(9):1330-4. PubMed ID: 9286748
[TBL] [Abstract][Full Text] [Related]
19. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
Kim H; Yang XL; Rosada C; Hamilton SR; August JT
Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas.
Samander EH; Arnold A
J Clin Endocrinol Metab; 2006 Dec; 91(12):5019-21. PubMed ID: 17003089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
